Intracellular molecular signaling: Basis for specificity to glucocorticoid anti-inflammatory actions

Annals of the New York Academy of Sciences

Volumn 1153, Issue , 2009, Pages 6-13

  Liberman, Ana C ^a,b   Druker, Jimena ^a,b   Garcia, Fernando Aprile ^a   Holsboer, Florian ^c   Arzt, Eduardo ^a,b  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

^b Consejo Nacional de Investigaciones Científicas Y Técnicas ^*

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

GATA 3; Glucocorticoids; RSUME; SUMO; T bet

Indexed keywords

CYTOKINE; DEAD BOX PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PROTEASOME; RING FINGER PROTEIN; SUMO PROTEIN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UBIQUITIN;

ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN PROCESSING; RING FINGER MOTIF; SIGNAL TRANSDUCTION; SUMOYLATION; TH1 CELL; TH2 CELL; TRANSCRIPTION REGULATION;

EID: 60349114682     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03958.x     Document Type: Conference Paper

References (58)

1. Besedovsky, H.O. & A. del Rey. 1992. Immune-neuroendocrine circuits: integrative role of cytokines. Front Neuroendocrinol. 13 : 61 94.
2. De Bosscher, K., W. Vanden Berghe & G. Haegeman. 2003. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24 : 488 522.
3. Ashwell, J.D., F.W. Lu & M.S. Vacchio. 2000. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18 : 309 345.
4. Liberman, A.C. et al. 2007. Glucocorticoids in the regulation of transcription factors that control cytokine synthesis. Cytokine Growth Factor Rev. 18 : 45 56.
5. Abbas, A.K., K.M. Murphy & A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383 : 787 793.
6. Mosmann, T.R. & R.L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7 : 145 173.
7. Parronchi, P. et al. 1992. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149 : 2977 2983.
8. Oriss, T.B. et al. 1997. Crossregulation between T helper cell (Th)1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1. J. Immunol. 158 : 3666 3672.
9. Manetti, R. et al. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177 : 1199 1204.
10. Szabo, S.J. et al. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 : 655 669.
11. Zhang, D.H. et al. 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272 : 21597 21603.
12. Szabo, S.J. et al. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295 : 338 342.
13. Zhu, J. et al. 2004. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat. Immunol. 5 : 1157 1165.
14. Zheng, W. & R.A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89 : 587 596.
15. Ferber, I.A. et al. 1999. GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels. Clin. Immunol. 91 : 134 144.
16. Robinson, D.S. & A. O'Garra. 2002. Further checkpoints in Th1 development. Immunity 16 : 755 758.
17. Mullen, A.C. et al. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292 : 1907 1910.
18. Afkarian, M. et al. 2002. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3 : 549 557.
19. Neurath, M.F. et al. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195 : 1129 1143.
20. Hwang, E.S. et al. 2005. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307 : 430 433.
21. Ho, I.C. et al. 1991. Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene. Embo J. 10 : 1187 1192.
22. Zhang, D.H. et al. 1999. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 11 : 473 482.
23. Chen, C.H. et al. 2000. Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J. Immunol. 165 : 5597 5605.
24. Maneechotesuwan, K. et al. 2007. Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J. Immunol. 178 : 2491 2498.
25. Kovalovsky, D. et al. 2000. Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production. J. Neuroimmunol. 109 : 23 29.
26. Ramirez, F. et al. 1996. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156 : 2406 2412.
27. Visser, J. et al. 1998. Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood 91 : 4255 4264.
28. Wu, C.Y. et al. 1991. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur. J. Immunol. 21 : 2645 2647.
29. Chen, R. et al. 2000. Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter. J. Immunol. 164 : 825 832.
30. Mori, A. et al. 1997. Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. Blood 89 : 2891 2900.
31. Refojo, D. et al. 2003. Integrating systemic information at the molecular level: cross-talk between steroid receptors and cytokine signaling on different target cells. Ann. N. Y. Acad. Sci. 992 : 196 204.
32. Liberman, A.C., D. Refojo & E. Arzt. 2003. Cytokine signaling/transcription factor cross-talk in T cell activation and Th1-Th2 differentiation. Arch. Immunol. Ther. Exp. (Warsz.) 51 : 351 365.
33. Liberman, A.C. et al. 2007. The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. Faseb J. 21 : 1177 1188.
34. Young, H.A. & K.J. Hardy. 1990. Interferon-gamma: producer cells, activation stimuli, and molecular genetic regulation. Pharmacol. Ther. 45 : 137 151.
35. Boumpas, D.T. et al. 1993. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Intern. Med. 119 : 1198 1208.
36. Quan, A., M.N. McCall & W.A. Sewell. 2001. Dexamethasone inhibits the binding of nuclear factors to the IL-5 promoter in human CD4 T cells. J. Allergy Clin. Immunol. 108 : 340 348.
37. Jee, Y.K. et al. 2005. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment. J. Biol. Chem. 280 : 23243 23250.
38. Biola, A. et al. 2000. The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes. FEBS Lett. 487 : 229 233.
39. Franchimont, D. et al. 2000. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J. Immunol. 164 : 1768 1774.
40. Zhang, D.H., L. Yang & A. Ray. 1998. Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J. Immunol. 161 : 3817 3821.
41. Miyaura, H. & M. Iwata. 2002. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J. Immunol. 168 : 1087 1094.
42. Ramirez, F. 1998. Glucocorticoids induce a Th2 response in vitro. Dev. Immunol. 6 : 233 243.
43. Daynes, R.A. & B.A. Araneo. 1989. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol. 19 : 2319 2325.
44. Brinkmann, V. & C. Kristofic. 1995. Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO +subsets. J. Immunol. 155 : 3322 3328.
45. Blotta, M.H., R.H. DeKruyff & D.T. Umetsu. 1997. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4 +lymphocytes. J. Immunol. 158 : 5589 5595.
46. Hershko, A. & A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67 : 425 479.
47. Melchior, F. 2000. SUMO-nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol. 16 : 591 626.
48. Gill, G. 2004. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 18 : 2046 2059.
49. Hay, R.T. 2005. SUMO: a history of modification. Mol. Cell 18 : 1 12.
50. Desterro, J.M., M.S. Rodriguez & R.T. Hay. 1998. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 2 : 233 239.
51. Hay, R.T. et al. 1999. Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 354 : 1601 1609.
52. Carbia-Nagashima, A. & E. Arzt. 2004. Intracellular proteins and mechanisms involved in the control of gp130/JAK/STAT cytokine signaling. IUBMB Life 56 : 83 88.
53. Bossis, G. et al. 2005. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell Biol. 25 : 6964 6979.
54. Tirard, M. et al. 2007. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor. Mol. Cell Endocrinol. 268 : 20 29.
55. Poukka, H. et al. 2000. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. USA 97 : 14145 14150.
56. Le Drean, Y. et al. 2002. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 143 : 3482 3489.
57. Tian, S. et al. 2002. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem. J. 367 : 907 911.
58. Carbia-Nagashima, A. et al. 2007. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell 131 : 309 323.